IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Metformin for the Treatment of Diabetes in Pregnancy
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Soroka University Medical Center.
Recruitment status was: Not yet recruiting
Recruitment status was: Not yet recruiting
Sponsor:
Soroka University Medical Center
Collaborator:
Ben-Gurion University of the Negev
Information provided by:
Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT00414245
First received: December 20, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.
| Condition | Intervention | Phase |
|---|---|---|
| Gestational Diabetes Diabetes Mellitus Type 2 | Drug: metformin | Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Metformin for the Treatment of Diabetes in Pregnancy |
Resource links provided by NLM:
Further study details as provided by Soroka University Medical Center:
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- pregnant women
- GDM A2
- diabetes mellitus type 2
- singleton pregnancy
Exclusion Criteria:
- diabetic nephropathy or proliferative retinopathy
- cannot swallow tablets
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00414245
Please refer to this study by its ClinicalTrials.gov identifier: NCT00414245
Contacts
| Contact: Boaz Sheizaf, MD | 972-54-2401191 | bsheizaf@bgu.ac.il |
Locations
| Israel | |
| Division of Obstetrics and Gynecology, Soroka University Medical Center | Not yet recruiting |
| Beer-Sheva, Israel | |
| Contact: Boaz Sheizaf, MD 972-54-2401191 bsheizaf@bgu.ac.il | |
| Principal Investigator: Boaz Sheizaf, MD | |
Sponsors and Collaborators
Soroka University Medical Center
Ben-Gurion University of the Negev
Investigators
| Principal Investigator: | Boaz Sheizaf, MD | division of obstetrics and gynecology, soroka university medical center |
More Information
| ClinicalTrials.gov Identifier: | NCT00414245 History of Changes |
| Other Study ID Numbers: |
sor434306ctil |
| Study First Received: | December 20, 2006 |
| Last Updated: | December 20, 2006 |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes, Gestational Diabetes Mellitus, Type 2 Pregnancy in Diabetics Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Pregnancy Complications Metformin Hypoglycemic Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on July 26, 2017